Research Guide
How to size biotech markets without fooling yourself
Good market sizing separates epidemiology, diagnosed patients, treatable patients, eligible patients, pricing, reimbursement, duration, and competitive share. The useful number is not the biggest number; it is the defensible number.
What to check first
Start with the evidence that can change value: clinical relevance, regulatory path, competitive context, financing needs, and whether the company can reach the next milestone.
How Drugnews uses this guide
We apply these frameworks when writing company research, paid analysis, and client-facing content so that readers can follow the logic behind each judgment.